INOVIO Pharmaceuticals

INOVIO’s INO-3107 Shows Powerful Potential for Treating Recurrent Respiratory Papillomatosis

PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) has unveiled promising peer-reviewed results from its Phase 1/2 clinical trial for INO-3107, a cutting-edge DNA medicine designed to treat recurrent respiratory papillomatosis (RRP). …

INOVIO’s INO-3107 Shows Powerful Potential for Treating Recurrent Respiratory Papillomatosis Read More




Penn Medicine Park

Big Changes at Lancaster’s Ballpark! Penn Medicine Partnership Redefines the Game with Health & Wellness Goals

LANCASTER, PA — The Lancaster Stormers have unveiled a new chapter in their history, announcing their home stadium’s renaming to Penn Medicine Park. This rebranding follows a multi-year partnership with Penn …

Big Changes at Lancaster’s Ballpark! Penn Medicine Partnership Redefines the Game with Health & Wellness Goals Read More